— Le Journal RENASCOR · Dossier

CAR-T Cell Therapy: A Revolution in Cancer Treatment

CAR-T cell therapy involves reprogramming a patient's T lymphocytes to target and destroy cancer cells. A revolutionary innovation in immunotherapy, with spectacular results in certain leukemias and lymphomas.<\/p>

CAR-T Cell Therapy: A Revolution in Cancer Treatment<\/h2>

A New Era for Immunotherapy<\/h3>

For about a decade, immunotherapy has transformed the management of certain cancers. Among the most promising innovations is CAR-T cell therapy<\/strong> (Chimeric Antigen Receptor T-cells).<\/p>

This is a cutting-edge treatment that mobilizes the patient's own immune defenses, reprogrammed to specifically attack tumor cells.<\/p>

How Does CAR-T Treatment Work?<\/h3>
  1. Collection of T Lymphocytes<\/strong>: the patient's immune cells are collected through a procedure similar to a blood draw.<\/p> <\/li>

  2. Genetic Modification<\/strong>: in the laboratory, these lymphocytes are modified to express an artificial receptor (CAR) capable of recognizing a specific antigen present on the surface of cancer cells.<\/p> <\/li>

  3. Cell Expansion<\/strong>: the reprogrammed cells are multiplied by millions.<\/p> <\/li>

  4. Reinjection<\/strong>: they are then reinjected into the patient to selectively destroy tumor cells.<\/p> <\/li> <\/ol>

    In Which Cancers?<\/h3>

    CAR-T cells are currently used in certain resistant or relapsed hematological malignancies, including:<\/p>

    • Acute Lymphoblastic Leukemia<\/strong> (children and young adults)<\/p> <\/li>

    • Diffuse Large B-Cell Lymphoma<\/strong><\/p> <\/li>

    • Multiple Myeloma<\/strong><\/p> <\/li> <\/ul>

      New clinical trials are gradually expanding the scope to other hematological cancers and, eventually, perhaps to solid tumors.<\/p>

      Observed Benefits<\/h3>
      • Complete remissions in patients with no other therapeutic alternatives.<\/p> <\/li>

      • Very precise targeting of diseased cells.<\/p> <\/li>

      • Sometimes a single injection may be sufficient, unlike chronic treatments.<\/p> <\/li> <\/ul>

        Current Limitations and Challenges<\/h3>
        • Sometimes severe side effects, such as cytokine release syndrome<\/strong> or neurological impairments.<\/p> <\/li>

        • An extremely high cost, often exceeding €300,000 per treatment.<\/p> <\/li>

        • A complex production process, requiring highly specialized laboratories.<\/p> <\/li> <\/ul>

          And After Treatment?<\/h3>

          Even though CAR-T cells represent a major advancement, patients often face physical and psychological side effects. Reconstruction, particularly hair restoration, remains an important step in moving past the disease.<\/p>

          This is precisely where Laboratory RENASCOR<\/strong> comes in, a global specialist in post-cancer hair restoration<\/strong>. With its unique care, we support patients beyond the therapeutic protocol, helping them regain confidence, identity, and quality of life.<\/p>

          <\/p>

— À lire ensuite —

Articles similaires